Pathology in Continuous Infusion Studies in Rodents andNon-Rodents and ITO (Infusion Technology Organisation)-Recommended Protocol for Tissue Sampling and Terminology for Procedure-Related Lesions
-
- Weber Klaus
- AnaPath GmbH
-
- Mowat Vasanthi
- Huntingdon Life Sciences
-
- Hartmann Elke
- Bayer Schering Pharma AG
-
- Razinger Tanja
- Harlan Laboratories Ltd.
-
- Chevalier Hans-Jörg
- AnaPath GmbH
-
- Blumbach Kai
- Harlan Laboratories Ltd.
-
- Green Owen P.
- LeVerts Ltd Consultancy
-
- Kaiser Stefan
- Harlan Laboratories Ltd.
-
- Corney Stephen
- Harlan Laboratories Ltd.
-
- Jackson Ailsa
- Harlan Laboratories Ltd.
-
- Casadesus Agustin
- Harlan Laboratories S.A.
この論文をさがす
説明
Many variables may affect the outcome of continuous infusion studies. The results largely depend on the experience of the laboratory performing these studies, the technical equipment used, the choice of blood vessels and hence the surgical technique as well the quality of pathological evaluation. The latter is of major interest due to the fact that the pathologist is not involved until necropsy in most cases, i.e. not dealing with the complicated surgical or in-life procedures of this study type. The technique of tissue sampling during necropsy and the histology processing procedures may influence the tissues presented for evaluation, hence the pathologist may be a source of misinterpretation. Therefore, ITO proposes a tissue sampling procedure and a standard nomenclature for pathological lesions for all sites and tissues in contact with the port-access and/or catheter system.
収録刊行物
-
- Journal of Toxicologic Pathology
-
Journal of Toxicologic Pathology 24 (2), 113-124, 2011
日本毒性病理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204413781504
-
- NII論文ID
- 130000930501
-
- NII書誌ID
- AN10232280
-
- ISSN
- 1881915X
- 09149198
-
- NDL書誌ID
- 11170407
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可